These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26043560)

  • 1. [Treating non-alcoholic fatty liver disease patients of Gan stagnation Pi deficiency syndrome by tiaogan lidi recipe: a randomized controlled clinical trial].
    Yu Q; Zhang SS; Zhou T; Xiong Y; Zhao LQ; Ding Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Apr; 35(4):401-5. PubMed ID: 26043560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of nonalcoholic steatohepatitis by Jianpi Shugan Recipe: a multi-center, randomized, controlled clinical trial].
    Li JX; Wang YL; Liu M; Liu SN; Xu CJ; Zhao J; Shi R; Su DM; Zhuge L; Chen X; Yu YQ; Li L; Xie CE; Hu LM; Zhang C
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):15-9. PubMed ID: 24520780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial].
    Tian LY; Lu LG; Tang CW; Xie Y; Luo HS; Tan SY; Pang Z; Zhang YL; Gong LB; Li YM; Chen SH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):528-32. PubMed ID: 24074713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of Zaozhu Yinchen Recipe for Treating Non-alcoholic Steatohepatitis and its Effect on Free Fatty Acid and TNF-alpha].
    Tang JM; Liang HQ; Wang HG; Lin MT; Zhang LM; Chen SD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):544-8. PubMed ID: 27386644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
    J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis].
    Liu XD; Wang M; Li YZ
    Zhongguo Zhen Jiu; 2010 Aug; 30(8):637-41. PubMed ID: 20942279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
    Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of early and mid-term primary biliary cirrhosis by Qingying Huoxue Decoction Combined ursodeoxycholic acid: a clinical observation].
    Fu DC; Hua Z; Li YG; Wu HY; Guo XY; Huang JZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):290-3. PubMed ID: 25951632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy: a randomized controlled trial].
    Huang Z; Song S; Tan K; Chu J; Zhu X; Zeng Y
    Zhongguo Zhen Jiu; 2016 Feb; 36(2):119-23. PubMed ID: 27348904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease: a randomized controlled trial].
    Lou SY; Liu Y; Ma YY; Chen HY; Chen WH; Ying J; He YM; Wang WJ
    Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):793-8. PubMed ID: 18664346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Darvish Damavandi R; Shidfar F; Najafi M; Janani L; Masoodi M; Akbari-Fakhrabadi M; Dehnad A
    Phytother Res; 2021 Jun; 35(6):3145-3156. PubMed ID: 33880813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
    Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.